The deal range was $12.87-$13.09. RBC Capital acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRMD:
- Closing Bell Movers: Nike gains 10% on more positive earnings call
- CorMedix announces $85M common stock offering
- CorMedix’s Promising Growth: Buy Rating Backed by Strong DefenCath Launch and Strategic Partnerships
- CorMedix Holds Annual Stockholders Meeting, Approves Key Proposals
- CorMedix Expands DefenCath Implementation with Major Client